(EYEG) Eyegate Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Eyegate Pharmaceuticals | (EYEG) share price targets
Complete technical analysis of Eyegate Pharmaceuticals (EYEG) by charts plus indicators, forecast predictions and share price targets for Eyegate Pharmaceuticals (EYEG)
Eyegate Pharmaceuticals trades in USA in Health Care sector.
Showing technical analysis as on 2024-08-28 View latest technical analysis
10 day averaged volume of Eyegate Pharmaceuticals is 1727
| Date | Daily Closing Price | Open | High | Low | Volume |
| 28 Wed Aug 2024 | 36.64 | 36.72 | 36.72 | 36.64 | 0.521 times |
| 27 Tue Aug 2024 | 36.69 | 36.64 | 36.69 | 36.64 | 0.116 times |
| 26 Mon Aug 2024 | 36.72 | 36.69 | 36.72 | 36.69 | 5.79 times |
| 23 Fri Aug 2024 | 36.73 | 36.73 | 36.75 | 36.68 | 1.158 times |
| 22 Thu Aug 2024 | 36.57 | 36.53 | 36.60 | 36.53 | 0.811 times |
| 21 Wed Aug 2024 | 36.73 | 36.73 | 36.75 | 36.73 | 0.521 times |
| 20 Tue Aug 2024 | 36.64 | 36.64 | 36.64 | 36.64 | 0 times |
| 19 Mon Aug 2024 | 36.57 | 36.57 | 36.57 | 36.57 | 1.312 times |
| 16 Fri Aug 2024 | 36.47 | 36.47 | 36.48 | 36.47 | 0.058 times |
| 15 Thu Aug 2024 | 36.39 | 36.39 | 36.39 | 36.36 | 0.174 times |
My analysis of stock is bullish for shortterm, but stock is in semi over bought zones and there are some chances of seeing a fall tomorrow. Use 36.7 as stoploss in an intra day sell trade for a target of 36.41. However, stock will show a bullish move above 36.7.
Share price targets for Eyegate Pharmaceuticals (EYEG)
| Target Type | Value |
| Downside Target | 34.52 |
| Downside Target | 36.10 |
| Downside Target | 36.38 |
| Downside Target | 36.42 |
| Downside Target | 36.49 |
| Downside Target | 36.53 |
| Downside Target | 36.64 |
| Upside Target | 36.72 |
| Upside Target | 36.75 |
Intraday share price targets for Eyegate Pharmaceuticals (EYEG)
| Target Type | Value |
| Downside Intraday Target | 36.61 |
| Downside Intraday Target | 36.59 |
| Upside Intraday Target | 36.69 |
| Upside Intraday Target | 36.75 |
| Upside Intraday Target | 36.67 |
Weekly technical analysis of Eyegate Pharmaceuticals (EYEG)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 28 Wed Aug 2024 | 36.64 | 36.69 | 36.72 | 36.64 | 1.691 times |
| 23 Fri Aug 2024 | 36.73 | 36.57 | 36.75 | 36.53 | 4.377 times |
| 16 Fri Aug 2024 | 36.47 | 36.11 | 36.49 | 36.10 | 0.536 times |
| 09 Fri Aug 2024 | 36.11 | 36.25 | 36.38 | 35.96 | 0.743 times |
| 02 Fri Aug 2024 | 36.42 | 35.82 | 36.42 | 35.82 | 7.54 times |
Price has moved down this week, and volume has increased substantially. This means that the move can continue in coming weeks.
Monthly technical analysis of Eyegate Pharmaceuticals (EYEG)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 28 Wed Aug 2024 | 36.64 | 36.08 | 36.75 | 35.96 | 1.9 times |
| 31 Wed Jul 2024 | 36.09 | 35.02 | 36.09 | 35.02 | 3.018 times |
| 28 Fri Jun 2024 | 35.36 | 35.28 | 35.70 | 35.19 | 0.302 times |
| 31 Fri May 2024 | 35.26 | 34.71 | 35.42 | 34.71 | 0.4 times |
Scroll below to view daily charts
Price has moved up this month, and volume has increased substantially. This means that the move can continue in coming months.
Indicators analysis of Eyegate Pharmaceuticals (EYEG)
Price action analysis of Eyegate Pharmaceuticals ( (EYEG) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Eyegate Pharmaceuticals ( (EYEG) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Eyegate Pharmaceuticals ( (EYEG) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Eyegate Pharmaceuticals ( (EYEG) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Eyegate Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Eyegate Pharmaceuticals in short term and the buy signal is strong.
Eyegate Pharmaceuticals Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Eyegate Pharmaceuticals in short term but SELL signal is weak.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Eyegate Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 36.68 and Eyegate Pharmaceuticals (EYEG) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Eyegate Pharmaceuticals (EYEG) stock. Volume based technical analysis of Eyegate Pharmaceuticals (EYEG) stock is negative.
Eyegate Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Eyegate Pharmaceuticals ( (EYEG) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Eyegate Pharmaceuticals ( (EYEG) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Eyegate Pharmaceuticals ( (EYEG) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Eyegate Pharmaceuticals ( (EYEG) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Eyegate Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Eyegate Pharmaceuticals in short term and the buy signal is strong.
Eyegate Pharmaceuticals Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Eyegate Pharmaceuticals in short term but SELL signal is weak.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Eyegate Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 36.68 and Eyegate Pharmaceuticals (EYEG) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Eyegate Pharmaceuticals (EYEG) stock. Volume based technical analysis of Eyegate Pharmaceuticals (EYEG) stock is negative.
Eyegate Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.